Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Novel Equation for Estimating Resting Energy Expenditure

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03377413
Recruitment Status : Completed
First Posted : December 19, 2017
Last Update Posted : October 14, 2020
Sponsor:
Information provided by (Responsible Party):
Dong Jie, Peking University First Hospital

Study Description
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Brief Summary:
The energy and nutrition states are closely associated with CKD patients complications and outcomes.To reach the energy balance target, we need the accurate resting energy expenditure level of patients. Traditional equations are not applicable to CKD patients,so we aim to develop and validate a equation for estimating resting energy expenditure in CKD patients.

Condition or disease
Resting Energy Expenditure Chronic Kidney Disease

Study Design
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Layout table for study information
Study Type : Observational
Actual Enrollment : 300 participants
Observational Model: Case-Only
Time Perspective: Cross-Sectional
Official Title: Novel Equation for Estimating Resting Energy(REE) Expenditure in Chronic Kidney Disease(CKD) 3-5 Stages Patients
Actual Study Start Date : December 14, 2017
Actual Primary Completion Date : January 31, 2020
Actual Study Completion Date : February 1, 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Kidney Diseases

Groups and Cohorts
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information


Outcome Measures
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Primary Outcome Measures :
  1. Novel equation development [ Time Frame: September 1, 2017 to June 1, 2018 ]
    Developed equation for estimating REE in CKD 3-5 stages patients

  2. Novel equation validation [ Time Frame: June 1, 2018 to March 1, 2019 ]
    Validate the noval equation with REE obtained by indirect calorimetry (IC).


Eligibility Criteria
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
chronic kidney disease 3-5 stages
Criteria

Inclusion Criteria:

  • CKD 3-5 stages
  • Age:18-80 years old

Exclusion Criteria:

  • Dialysis and kidney transplantation;
  • Acute complications to hospitalization
  • 1 month prior to the study;
  • Acute or chronic infections, cancer and other wasting diseases in the past year;
  • Thyroid dysfunction;
  • Acute onset of podagra; Musculoskeletal diseases;
  • Respiratory diseases (asthma, pleural effusion, pneumothorax, COPD);
  • History of hormonal drugs use;
  • During pregnancy or lactation
Contacts and Locations
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03377413


Locations
Layout table for location information
China, Beijing
Renal Division and Institute of Nephrology, Peking University First Hospital
Beijing, Beijing, China, 100034
Sponsors and Collaborators
Peking University First Hospital
Investigators
Layout table for investigator information
Study Director: Jie Dong Renal Division and Institute of Nephrology, Peking University First Hospital
More Information
Go to 
Top of Page Study Description Study Design Groups and Cohorts Outcome Measures Eligibility Criteria Contacts and Locations More Information
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):

Layout table for additonal information
Responsible Party: Dong Jie, Clinical Professor in Renal Division, Department of Medicine, Peking University First Hospital
ClinicalTrials.gov Identifier: NCT03377413    
Other Study ID Numbers: REE equation
First Posted: December 19, 2017    Key Record Dates
Last Update Posted: October 14, 2020
Last Verified: October 2020

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Additional relevant MeSH terms:
Layout table for MeSH terms
Kidney Diseases
Renal Insufficiency, Chronic
Urologic Diseases
Renal Insufficiency